Table 4 Comparison between levels of MMP-1 as regard to diagnosis of the CLD group

15.1 ± 1.9

11.5‑21.5

F = 2.6

0.071

Cholestasis

Biliary atresia

12.7 ± 3.4

6‑18.5

Familial intrahepatic cholestasis

13.3 ± 2.3

8‑15.5

Viral hepatitis

HBV

14.7 ± 2.6

12.5‑17

HCV

15.9 ± 1.6

15.5‑19

14.5 ± 2.8

9.1‑16

Metabolic liver diseases

Glycogen storage disease

16.6 ± 3.9

12‑20.5

Wilson disease

13.4 ± 3.9

7.1‑19

Tyrosinemia

14.3 ± 1.6

5‑19

Neiman pick

12.5 ± 1.5

8.5‑15

16.1 ± 5.5

6‑19.5